Although the present cohort is representative of patients who are referred in dementia clinics, future studies with larger sample sizes with more pathology-specific markers and genotyping (including APOE) may be able to clarify the interaction between innate immune system and co-pathologies across all syndromes. The gene discussed is APOE; the disease is dementia.